Titlebook: Current Cancer Therapeutics; John M. Kirkwood,Michael T. Lotze,Joyce M. Yasko Book 2001Latest edition Springer Science+Business Media New

necrosis

书目名称Current Cancer Therapeutics影响因子(影响力)




书目名称Current Cancer Therapeutics影响因子(影响力)学科排名




书目名称Current Cancer Therapeutics网络公开度




书目名称Current Cancer Therapeutics网络公开度学科排名




书目名称Current Cancer Therapeutics被引频次




书目名称Current Cancer Therapeutics被引频次学科排名




书目名称Current Cancer Therapeutics年度引用




书目名称Current Cancer Therapeutics年度引用学科排名




书目名称Current Cancer Therapeutics读者反馈




书目名称Current Cancer Therapeutics读者反馈学科排名

设想

聪明

音乐会

Wireless Sensor Networks Essentials The incidence of melanoma has risen more rapidly than any other solid tumor. Approximately 45,000 patients develop melanoma annually, with one in 75 white patients expected to be at risk for developing melanoma in their lifetime at the beginning of this millennium [1]. Interestingly, the increase a

concubine

Biologic Agentsstim). Although they do not have direct antitumor activity, these recombinant proteins blunt chemotherapy-induced myelopoietic toxicity, and have become useful adjuvants to bone marrow transplantation and aggressive chemotherapeutic regimens.

configuration

Lung Cancerh previous chemotherapeutic approaches [2]. A small minority of patients, between 15% and 25%, with advanced regional disease stage III with either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC) may be cured with intensive combined-modality approaches. Surgery cures 10% to 80% o

configuration

Melanoma and Other Tumors of the Skin The incidence of melanoma has risen more rapidly than any other solid tumor. Approximately 45,000 patients develop melanoma annually, with one in 75 white patients expected to be at risk for developing melanoma in their lifetime at the beginning of this millennium [1]. Interestingly, the increase a

新鲜

失望昨天

978-1-57340-176-0Springer Science+Business Media New York 2001

血统